This section provides lists details of new items added to the site as well as a full archive of our press releases. It also includes our Press Office contacts and a photo and image library of downloadable images suitable for print output.
Frequent visitors should click the Refresh button to ensure the latest version of this page is displayed.
-
We have identified a problem with the Yellow Card postal delivery service. Some Yellow Cards have been returned to sender due to an error at Royal Mail.
-
We have become aware that there have been a number of calls made to companies recently from people purporting to be members of MHRA staff, but who do not work for the Agency.
-
The Medicines and Healthcare products Regulatory Agency (MHRA) is warning consumers of the dangers of buying medicines from unregulated websites after the discovery in the United States of counterfeit Alli, a weight loss drug.
-
The MHRA and the Appointments Commission are pleased to announce the re-appointment of the Chair and one member to the Advisory Board on the Registration of Homeopathic Products.
-
The European-wide review of the anti-obesity drug sibutramine (Reductil) has concluded and an opinion reached recommending the suspension of the licence for the medicine across Europe.
-
The British Pharmacopoeia (BP) Commission and the Appointments Commission are pleased to announce the appointment and re-appointment of members to the BP Commission.
-
We have been developing an area for healthcare professional groups on our website and today we have launched a new section for staff at care homes, which includes guidance, safety alerts and links to educational material to assist care home staff in the safe use and management of medicines and medical devices.
-
The Ministerial Industry Strategy Group (MISG) asked us to explore the introduction of a scheme in the UK to make certain new and promising medicines available to patients before they are formally licensed and a framework was proposed. The MHRA will undertake a public consultation on the scheme in the New Year.
-
We have issued a precautionary Drug Alert on the recall of Dentinox Teething Gel 15g, due to the presence of very small amounts of a contaminant, glyoxal, in the product.
-
We have issued a Drug Alert about a batch recall of Metatone Tonic 300 ml due to the presence of very small amounts of petrol in the medicine. There is currently no evidence of harm and no suspected adverse drug reactions have been reported.